Dr. Scott Hayworth trained as an OB-GYN and is currently President and CEO of CareMount Medical, P.C. (formerly Mount Kisco Medical Group, P.C.). In his 18 years as President and CEO, Scott has transformed the medical group from 40 physicians and 3 locations to 550 physicians and 41 locations. He has served major leadership roles including Chairman of the American Medical Group Association (AMGA) and the National Executive Board of the American Congress of Obstetricians and Gynecologists (ACOG). He is currently on the board of a number of private equity-backed companies, a Senior Advisor at Arsenal Capital, and an Associate Dean at the Icahn School of Medicine at Mount Sinai.
Jack Goldstein’s most recent operating role was as President and COO of Chiron Corporation, which had approximately $2B in revenues with a market cap of $9.5B and included biopharmaceuticals, vaccines, and transfusion diagnostics. Chiron was acquired by Novartis in a multi-billion dollar transaction in 2006. Prior to this, Jack was CEO of Applied Imaging and held several executive management positions at J&J, including President of Ortho Diagnostic Systems. He has served on the boards of Illumina, Orasure, and Immucor and is currently on the board of Accuray and Chairman of the Board of OncoGenex Pharmaceuticals.
Counsyl co-founder and CEO, Ramji Srinivasan, said of the new board members, "As a practicing physician, Scott intimately understands the role that genetic testing can play in the modern physician's office. His perspective will help us provide the best possible experience for physicians and patients. Jack's experience with growing companies and improving operations will benefit Counsyl as we continue our clinical expansion. Scott and Jack serve as very strong clinical and medical complements to our board and we're thrilled to have them on the team."
Counsyl is a DNA testing and genetic counseling service. We're committed to helping you understand your DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide you with early awareness about genetic conditions, so you can live informed and prepare for the future.
Every Counsyl test starts with a conversation with your healthcare provider and includes a consultation with a board-certified genetic counselor. Our automated clinical lab enables results delivery at industry-leading speeds for a fraction of the average cost. Counsyl has screened more than 550,000 patients and served more than 6,000 health care professionals. For more information, visit www.counsyl.com.